Atlas Trials

The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray

Clinical trial NCT06127498 · UNKNOWN

Trial details

NCT number
NCT06127498
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV-2Prevention
Start date
2022-05-01
Primary completion
2023-12-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.